Jaguar Health Inc JAGX shares are trading lower by some 7.73% to $5.01 going into the close of Tuesday's session. The company on Tuesday effected a reverse stock split of its issued and outstanding voting common stock at an exchange ratio of 1-for-75. The reverse stock split was effected in order to support the company's compliance with Nasdaq's listing standards.
See Also: What's Going On With Intuitive Surgical (ISRG) Shares?
The company on Monday also announced establishment of a board of directors for the newly formed joint venture Magdalena Biosciences.
Jaguar says that Dr. Karen Brunke, Jaguar's EVP of Corporate and Business Development, has been appointed acting Chief Executive Officer of Magdalena.
According to data from Benzinga Pro, JAGX has a 52-week high of $66.75 and a 52-week low of $5.00.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
